Tag Archives: healthcare

Igniting the Tipping Point between Digital Health and Pharma


In 2016, the digital transformation in healthcare is poised to shift from a silently rising tide to a tumultuous, crashing wave. (The sound of innovation will be especially audible June 6 and 7 at BIO 2016 in San Francisco.) A survey last year by the trend-watchers at Russell Reynolds Associates found that 47 percent of healthcare executives thought that their business would be “moderately or massively disrupted by digital in the next 12 months.” If Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Mesothelioma: Once Hopeless Cancer, on the Verge of Promising Advances


Mesothelioma, the word, (pronounced mez-uh-thee-lee-oh-muh) is often much better known than the illness it represents. The legal issues surrounding this cancer make mesothelioma, the most expensive keyword on Google (while most keywords cost pennies, the keyword mesothelioma can cost over $300 per click). Mesothelioma, the illness, is a cancer that most often affects the lining of the lung or abdomen; it has no cure and treatment options for patients are few. Prognosis is generally considered Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,

Roll Call: Patient-Centeredness, Comparative Effectiveness, and Value

In Roll Call, Tony Coelho former House Majority Whip, Chairman of the Partnership to Improve Patient Care (PIPC) and author of the Americans with Disabilities Act (ADA) discussed the need for a patient-centered approach to healthcare. Coelho says: “Policymakers talk about the “value” of treatments as if there is one value algorithm that applies to all patients equally. While that may be true in academia, in the real world value is personal. Research on treatment Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Wall Street Journal: Patients Deserve Better


In case you missed it, The Wall Street Journal published my Letter to the Editor this morning.  I make the point that the problem isn’t innovative new treatments from America’s biopharma industry but rather the complex web of health-insurance schemes patients must navigate to access needed medicines. Here is the text of the letter: “Innovative treatments and cures have radically transformed how we treat disease—saving and improving lives and providing tremendous benefits to patients and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,

WSJ Article Cherry Picks Cost, Ignores Value of Medicines

Jim Greenwood

Today’s Wall Street Journal story, “Price Increases Drive Drug Firms’ Revenue” reaffirms that old chestnut, “…a little information is a dangerous thing…”  When speaking to the complexities of the costs and benefits of America’s healthcare system, a publication like the Wall Street Journal should not cherry pick one aspect of that system to cover while ignoring the rest. Unfortunately and uncharacteristically, in this case, the paper focused on particular costs while ignoring value. In fact, Read More >

Health  |  1 Comment  |  Email This Post
Tags: ,